LR Kelland

DT-Diaphorase Expression and Tumor Cell Sensitivity to 17-Allylamino,17-demethoxygeldanamycin, an Inhibitor of Heat Shock Protein 90

LR Kelland, Swee Y. Sharp, Paul Rogers et al. · JNCI Journal of the National Cancer Institute · 1999 · 351 citations · Full text

Medicine, Oncology, Pharmacology +16

Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action.

Nicholas P. Farrell, LR Kelland, John D. Roberts et al. · PubMed · 1992 · 175 citations

Medicine, Oncology, Pharmacology +12

Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexes

Prakash Mistry, LR Kelland, G Abel · British Journal of Cancer · 1992 · 169 citations · Full text

Medicine, Oncology, Pharmacology +17

Induction of apoptosis by a novel copper-based anticancer compound, Casiopeina II, in L1210 murine leukaemia and CH1 human ovarian carcinoma cells

Andrea De Vizcaya‐Ruíz, Adolfo Rivero‐Müller, George E.N. Kass et al. · Toxicology in Vitro · 2000 · 133 citations

Medicine, Oncology, Pharmacology +14

In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin

Mellish Kj, LR Kelland, KR Harrap · British Journal of Cancer · 1993 · 113 citations · Full text

Medicine, Oncology, Pharmacology +12